Cite

1. Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med 2009;361(19):1872-1885.10.1056/NEJMra0902908Search in Google Scholar

2. Vardiman JW, Harris NL, Brunning RD.The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100(7):2292-302.10.1182/blood-2002-04-1199Search in Google Scholar

3. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007; 25(23): 3503-10.10.1200/JCO.2006.08.5696Search in Google Scholar

4. Greenberg P1, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6): 2079-208810.1182/blood.V89.6.2079Search in Google Scholar

5. Greenberg PL1, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D.Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012;120(12):2454-6510.1182/blood-2012-03-420489Search in Google Scholar

6. A Pardanani, A Tefferi. Cytogenetic risk stratification in myelodisplastic syndromes: Are we there yetJ J Clin ONcol 2012;30:2703-270410.1200/JCO.2012.42.5033Open DOISearch in Google Scholar

7. Wong AK, Fang B, Zhang L, Guo X, Lee S, Schreck R. Loss of the Y Chromosome An Age-Related or Clonal Phenomenon in Acute Myelogenous Leukemia/Myelodysplastic Syndrome? Arch Pathol Lab Med 2008;132:1329-3210.5858/2008-132-1329-LOTYCASearch in Google Scholar

8. Fenaux P, Mufti GJ, et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.Lancet Oncol 2009;10:223–32.10.1016/S1470-2045(09)70003-8Search in Google Scholar

9. Plaseski T, Noveski P, Trivodalieva S, Efremov GD, Plaseska-Karanfilska D.. Quantitative fluorescent-PCR detection of sex chromosome aneuploidies and AZF deletions/duplications. Genet Test. 2008;12(4):595-605.10.1089/gte.2008.006819072570Search in Google Scholar

10. Noveski P, Madjunkova S, Sukarova-Stefanovska E, Matevska Geshkovska N, Kuzmanovska M, Dimovski A, Plaseska-Karanfilska D. Loss of Y chromosome in peripheral blood of colorectal and prostate cancer patients. PLoS One. 2016;11(1):e014626410.1371/journal.pone.0146264470641126745889Search in Google Scholar

11. Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, Ebert BL. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015; 126(1): 9–16.10.1182/blood-2015-03-631747462444325931582Search in Google Scholar

12. Itzykson R1, Thépot S, Quesnel B, Dreyfus F, Beyne-Rauzy O, Turlure P, Vey N, Recher C, Dartigeas C, Legros L, Delaunay J, Salanoubat C, Visanica S, Stamatoullas A, Isnard F, Marfaing-Koka A, de Botton S, Chelghoum Y, Taksin AL, Plantier I, Ame S, Boehrer S, Gardin C, Beach CL, Adès L, Fenaux P; Groupe Francophone des Myelodysplasies(GFM). Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine. Blood 2011;117:403-41110.1182/blood-2010-06-28928020940414Search in Google Scholar

13. Bruce D. Cheson, Peter L. Greenberg, John M. Bennett, et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 2006; 108(2):419-2510.1182/blood-2005-10-414916609072Search in Google Scholar

eISSN:
1857-8985
ISSN:
1857-9345
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Basic Medical Science, History and Ethics of Medicine, Clinical Medicine, other, Social Sciences, Education